Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial
In ODYSSEY OUTCOMES (Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab), alirocumab was compared with placebo, added to high-intensity or maximum tolerated statin treatment after acute coronary syndrome in 18 924 patients. Alirocumab reduced firs...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2019
|
| Sorozat: | CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES
12 No. 11 |
| Tárgyszavak: | |
| doi: | 10.1161/CIRCOUTCOMES.119.005858 |
| mtmt: | 32687903 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/27011 |